Blueberrypharmaceuticals

Lapahope 250MG Lapahope 250mg tablets are categorized as anti-neoplastic agent, which is orally active drug used for treating breast cancer. Lapahope tablets are comes under biological category which is targeted chemotherapy. Lapahope tablets are classified as; 1. Tyrosine kinase prohibitor 2. Stop the HER2/neu& epidermal growth factor receptor activity 3. Targeted therapy  4. Signal transduction prohibitor MECHANISM OF ACTION Chemically Lapatinib is categorized as 4-anilinoquinazoline derivative, which expels anti-cancer activity by prohibiting intracellular tyrosine kinase domains of EFGR & HER type 2. The ErbB driven tumor cell production has been prohibited by Lapatinib. This growth factor receptor present on cell surface of tumors which may leads to cause cell death. PRODUCT DETAILS Brand                  Lapahope Ingredients          Lapatinib Strength              250mg Manufactured      Natco METABOLISM Lapatinib is a

HERDUO 250MG Herduo 250mg tablets are categorized as anti-neoplastic agent, which is orally active drug used for treating breast cancer. Herduo tablets are comes under biological category which is targeted chemotherapy. Herduo tablets are classified as; 1. Tyrosine kinase prohibitor 2. Stop the HER2/neu& epidermal growth factor receptor activity 3. Targeted therapy  4. Signal transduction prohibitor MECHANISM OF ACTION Chemically Lapatinib is categorized as 4-anilinoquinazoline derivative, which expels anti-cancer activity by prohibiting intracellular tyrosine kinase domains of EFGR & HER type 2. The ErbB driven tumor cell production has been prohibited by Lapatinib. This growth factor receptor present on cell surface of tumors which may leads to cause cell death. PRODUCT DETAILS Brand            Herduo Ingredients     Lapatinib Strength            250mg Manufactured    Natco METABOLISM Lapatinib is a substrate of P-g

CRIZALK 250MG DESCRIPTION Crizalk 250mg capsule is used for the therapy of patients with metastatic non-small cell lung cancer. Crizalk 250mg inhibits the anaplastic lymphoma kinase (ALK) and the c-MET/hepatocyte growth factor receptor. This action disturbs certain pathways in the cell, which can inhibit the growth of tumor cells. It is made specifically for the treatment of a type of lung cancer in which ALK is overactive due to an abnormality in the ALK gene. EXCRETION Crizalk is excreted via feces 63% and 22% via urine and half -life is 42 hours PRODUCT DETAILS Brand            Crizalk Ingredients     Crizotinib Strength            250mg Manufactured    Pfizer Ltd CRIZOTINIB SIDE EFFECTS • Infection increased • Breathlessness • Eyesight changes • Bowel changes • Feeling sick • Swelling of hands and feet’s • Decreased appetite • Fatigue • Liver changes • Skin rash • bradycardia STORAGE St

CRIZALK 200MG DESCRIPTION Crizalk 200mg capsule is used for the therapy of patients with metastatic non-small cell lung cancer. Crizalk 200mg belongs to type of tyrosine kinase inhibitor. Kinases are enzymes which are included in many functions, involving cell development and reproduction. MECHANISM OF ACTION More specifically, crizotinib inhibits anaplastic lymphoma kinase (ALK), hepatocyte growth factor receptor (HGFR, c-MET), and Recepteurd'OrigineNantais (RON).  Deformity in the ALK gene result by mutations or translocations may causes expression of oncogenic fusion proteins. Certain patients with NSCLC, they have the EML4-ALK gene. PRODUCT DETAILS Brand            Crizalk Ingredients    Crizotinib Strength            200mg Manufactured    Pfizer Ltd CRIZOTINIB SIDE EFFECTS • Infection increased • Breathlessness • Eyesight changes • Bowel changes • Feeling sick • Swelling of hands and feet’s • Decreased appet

GLENZA 40MG Glenza 40mg capsules belongs to nonsteroidal antiandrogen drug which is indicated for use in conjunction with castration to treat metastatic castration-resistant prostate cancer (mCRPC). Glenza capsule is in the form of liquid – filled soft gelatin capsules administer via oral route. Each capsule consists of 40mg enzalutamide in the form of solution in caprylocaproyl polyoxylglycerides. PRODUCT DETAILS Brand Glenza Ingredients Enzalutamide Strength 40mg Manufactured Glenmark Glenza 40mg tablet WHAT GLENZA CAPSULE IS USED FOR Glenza 40mg capsule is an anticancer medication which used for the treatment of patients with metastatic castration resistant prostate cancer. (i.e. surgical treatments that lower testosterone/ prostate cancer that is resistant to medical). ABSORPTION Rapid absorbs from GI tract. Time to peak plasma concentration is 1 hour (range 0.5 to 3 hours). OVER DOSAGE In overdose condition treatment with Glenza 40mg soli

AZEL 40MG Azel capsules belongs to nonsteroidal antiandrogen drug which is indicated for use in conjunction with castration to treat metastatic castration-resistant prostate cancer (mCRPC). Azel capsule is in the form of liquid – filled soft gelatin capsules administer via oral route. Each capsule consists of 40mg enzalutamide in the form of solution in caprylocaproyl polyoxylglycerides. WHAT AZEL CAPSULE IS USED FOR Azel 40mg capsule is an anticancer medication which used for the treatment of patients with metastatic castration resistant prostate cancer. (i.e. surgical treatments that lower testosterone/ prostate cancer that is resistant to medical). PRODUCT DETAILS Brand             Azel Ingredients     Enzalutamide Strength             40mg Manufactured     Dr. Reddy’s Azel 40mg tablet OVER DOSAGE In overdose condition treatment with Azel 40mg solid be stop and provide supportive measures care and monitor the vital signs. Multi

Bdenza 40mg Bdenza capsules belongs to nonsteroidal antiandrogen drug which is indicated for use in conjunction with castration to treat metastatic castration-resistant prostate cancer (mCRPC). Bdenza 40mg capsule is in the form of liquid – filled soft gelatin capsules administer via oral route. Each capsule consists of 40mg enzalutamide in the form of solution in caprylocaproyl polyoxylglycerides. PRODUCT DETAILS Brand Bdenza Ingredients Enzalutamide Strength 40mg Manufactured BDR Bdenza 40mg ENZALUTAMIDE SIDE EFFECTS MORE COMMON Back pain; bloating of the face, arms, hands, lower legs or feet; bloody urine; blurred vision; breathing difficulty; dizziness; loss of bowel control; nervousness. LESS COMMON Anxiety; confusion or excitement; nightmares; span problems; itching skin; pale-colored urine. RARE SIDE EFFECTS Seizures PREGNANCY Bdenza capsule is unsafe to use during pregnancy because the drug may cause harm to the

Xtandi 40mg Xtandi capsules belongs to nonsteroidal antiandrogen drug which is indicated for use in conjunction with castration to treat metastatic castration-resistant prostate cancer (mCRPC).  Xtandi 40mg capsule  is in the form of liquid – filled soft gelatin capsules administer via oral route. Each capsule consists of 40mg enzalutamide in the form of solution in caprylocaproyl polyoxylglycerides. PRODUCT DETAILS Brand Xtandi Ingredients Enzalutamide Strength 40mg Manufactured Astellas Xtandi 40mg tablet OVER DOSAGE In overdose condition treatment with Xtandi 40mg solid be stop and provide supportive measures care and monitor the vital signs. Multiple dose If administer ≤ 240mg no seizures is reported but when taking 360mg,480mg, and 600mg daily then 3 seizures were absorbed. If overdose occur, the patient will have high risk of seizures. ENZALUTAMIDE SIDE EFFECTS MORE COMMON Back pain; bloating of the face, arms, hands, lower leg

Soranib 200mg Tablet Sorafenib is pharmacologically categorized as protein kinase inhibitor, which is FDA approved compound used for the treatment of primary renal cell cancer in advanced stage, metastatic liver carcinoma (sorafenib liver cancer) and also involved in radioactive iodine resistant advanced thyroid cancer. Sorafenib is considered as synthetic compound aiming signal responding for growth and angiogenesis. Sorafenib works by blocking the enzyme RAF kinase, which is a demanding component of the RAF/MEK/ERK signaling pathway that dominates cell separation and multiplication. On the other hand, Sorafenib also prohibits the VEGFR-2/PDGFR-beta signaling force, through blockade of tumor angiogenesis. SORANIB (SORAFENIB) MECHANISM OF ACTION The activity of Soranib 200mg tablet containing Sorafenib is developing in-vitro. Soranib expels its activity by prohibiting assorted intracellular & cell surface kinase which is important for tumor cell signaling exudation, a

Sorafenat 200mg Tablet Sorafenib is pharmacologically categorized as protein kinase inhibitor, which is FDA approved compound used for the treatment of primary renal cell cancer in advanced stage, metastatic liver carcinoma (sorafenib liver cancer) and also involved in radioactive iodine resistant advanced thyroid cancer. Sorafenib is considered as synthetic compound aiming signal responding for growth and angiogenesis. Sorafenib works by blocking the enzyme RAF kinase, which is a demanding component of the RAF/MEK/ERK signaling pathway that dominates cell separation and multiplication. On the other hand, Sorafenib also prohibits the VEGFR-2/PDGFR-beta signaling force, through blockade of tumor angiogenesis. PRODUCT DETAILS Brand               Sorafenat Ingredients       Sorafenib Strength               200mg Manufactured       Natco Sorafenat 200mg tablet SORAFENAT (SORAFENIB) MECHANISM OF ACTION The activity of Sorafenat 200mg tablet co

Lanib 250mg Lanib consist of Lapatinib is primarily indicated for advanced breast cancer. Lanib is used in combination with capecitabine with Lanib tablets are usually indicated for the treatment of metastatic breast cancer patients in whose cancer cells expressed with EGFR 2 (HER2) and patients may already receive an anthracycline, taxane& Transtuzumab. PRODUCT DETAILS: Brand Lanib Ingredients Lapatinib Strength 250mg Manufactured BDR Lanib OVER DOSAGE: The doses of Lanib ranges from 2500mg to 9000mg daily, the duration of therapy should be varied between 1 & 17 days. Symptoms occurred during over dose of Lanib are Sore scalp, sinus tachycardia & mucosal inflammation. Patients should be providing with supportive measures. Hemodialysis is not an effective method for overcoming the over dosage condition of Lanib. SIDE EFFECTS: Diarrhea, Nausea, Vomiting, Stomatitis, Back